Susan Morrison, Executive Vice President and Chief Administrative Officer of Tandem Diabetes Care Inc. (NASDAQ:TNDM), filed a Form 4 on August 18, 2026, reporting four transactions in common stock on August 15, 2026, all related to the vesting of restricted stock units and associated tax withholding.

Key Highlights

  • RSU vesting, first grant: 1,097 shares were acquired on August 15, 2026 via RSU vesting at $0, from a grant awarded May 23, 2024 under the Tandem Diabetes Care 2023 Long-Term Incentive Plan.
  • Tax withholding, first grant: 314 shares were withheld by the issuer at $22.72 per share to satisfy tax obligations upon that vesting.
  • RSU vesting, second grant: 1,730 shares were acquired on August 15, 2026 via RSU vesting at $0, from a grant awarded May 30, 2025 under the same plan.
  • Tax withholding, second grant: 495 shares were withheld by the issuer at $22.72 per share to satisfy tax obligations upon that vesting.
  • Ending beneficial ownership: Following all four transactions, Morrison directly held 52,788 shares of common stock.
  • Remaining RSUs: After the reported transactions, Morrison held 3,290 RSUs from the May 2024 grant and 12,115 RSUs from the May 2025 grant.

RSU Vesting Activity for Tandem Diabetes Care's Chief Administrative Officer

According to the filing, all four transactions reported on August 15, 2026 relate to the vesting of restricted stock units granted to Morrison under the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended. The filing notes that each RSU "represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan." Tandem Diabetes Care is a medical device company focused on diabetes care products, with shares listed on NASDAQ under the symbol TNDM.

The filing describes the sequence of transactions as follows: first, 1,097 shares vested from the May 23, 2024 grant, bringing directly held shares to 51,867; then 314 shares were withheld at $22.72 per share for taxes, reducing the total to 51,553. Next, 1,730 shares vested from the May 30, 2025 grant, bringing the total to 53,283; then 495 shares were withheld at $22.72 per share for taxes, resulting in a final directly held total of 52,788 shares. The filing states explicitly that the withheld shares represent tax withholding requirements and that "no shares were sold."

Regarding vesting schedules, the filing discloses that one-third of the May 23, 2024 RSUs vested on May 15, 2025, with the remainder vesting in eight equal quarterly installments thereafter. For the May 30, 2025 grant, one-third vested on May 15, 2026, with the remaining RSUs also vesting in eight equal quarterly installments, subject to plan terms. The form was signed by Jerilyn Laskie as attorney-in-fact for Susan M. Morrison and dated August 18, 2026.

What Was Disclosed

The Form 4 reports RSU vestings totaling 2,827 shares acquired and 809 shares withheld for taxes at $22.72 per share across two grants under the 2023 Long-Term Incentive Plan, with Morrison directly holding 52,788 shares following all transactions.